Corvita Biomedical Inc. is a Canadian health technology company developing the ARK Incubator, an integrated neonatal intensive care platform designed to address systemic inequities in newborn diagnosis, reduce the prohibitive costs of delivering NICU services, and enable hospitals to scale their capacity without proportional increases in staffing or infrastructure.